Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Swiss children

References

• Spergel J, Paller A. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003;112:S118–27
   PubMed Web of Science ®Google Scholar
• Asher M, Montefort S, Björkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet 2006;368:733–43
   PubMed Web of Science ®Google Scholar
• Schulz Larsen F, Hanifin J. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 2002;22:1–24
   Web of Science ®Google Scholar
• Bergmann R, Edenharter G, Bergmann K, et al. Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy 1998;28:965–70
   PubMed Web of Science ®Google Scholar
• Halken S. Allergy Review Series VI: the immunology of fetuses and infants. The lessons of noninterventional and interventional prospective studies on the development of atopic disease during childhood. Allergy 2000;55:793–802
   PubMed Web of Science ®Google Scholar
• Exl B-M. A review of recent developments in the use of moderately hydrolyzed whey formulae in infant nutrition. Nutr Res 2001;21:355–79
   Web of Science ®Google Scholar
• von Berg A, Koletzko S, Filipiak-Pittroff B, et al. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: The German Infant Nutritional Intervention Study, a randomized double-blind trial. J Allergy Clin Immunol 2003;111:533–40
   PubMed Web of Science ®Google Scholar
• Baehler P, Baenziger O, Belli D, et al. Empfehlungen für die Säuglingsernährung 2009. Paediatrica 2009;20:13–5
   Google Scholar
• Lasarte Velillas J. Recomendaciones para la lactancia materna. Comité de Lactancia Materna de la Asociación Española de Pediatría. 2011;1–6 http://www.aeped.es/sites/default/files/lacmat-espanol.pdf [Last Accessed: December 23, 2011]
   Google Scholar
• Muche-Borowski C, Kopp M, Reese I, et al. Allergieprävention. AWMF Guideline Register 061/16, 2009
   Google Scholar
• Société Française de Dermatologie. Prise en charge de la dermatite atopique de l'enfant. Texte des recommandations. Ann Dermatol Vénéréol 2005;132:1S9–1S18
   Google Scholar
• World Health Organization and United Nations Children's Fund. Global strategy for infant and young child feeding. Geneva: NLM Classification: WS 120, 2003
   Google Scholar
• World Health Organization. World Health Organization's recommendations on breasfeeding. Available at: http://www.who.int/topics/breastfeeding/en. Accessed February 9, 2010
   Google Scholar
• von Berg A, Filipiak-Pittroff B, Krämer U, et al. Preventative effect of hydrolyzed formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). J Allergy Clin Immunol 2008;121:1442–7
   PubMed Web of Science ®Google Scholar
• von Berg A, Koletzko S, Filipiak-Pittroff B, et al. Certian hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study. J Allergy Clin Immunol 2007;119:718–25
   PubMed Web of Science ®Google Scholar
• Szajewska H, Horvath A. Meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases. Curr Med Res Opin 2010;26:423–37
   PubMed Web of Science ®Google Scholar
• Alexander D, Cabana M. Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis. J Pediatr Gastroenterol Nutr 2010;50:422–30
   PubMed Web of Science ®Google Scholar
• Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006;60:984–92
   PubMed Web of Science ®Google Scholar
• Kemp A. Cost of illness of atopic dermatitis in children. A societal perspective. PharmacoEconomics 2003;21:105–13
   PubMed Web of Science ®Google Scholar
• Ricci G, Bendandi B, Pagliara L, et al. Atopic dermatitis in Italian children: evaluation of its economic impact. JPediatr Health Care 2006;20:312–5
   Google Scholar
• Gieler U, Hohmann M, Niemeier V, et al. Cost evaluation in atopic eczema. J Dermatol Treat 1999;10:S15–S20
   Web of Science ®Google Scholar
• Weinmann S, Kamtsiuris P, Wickman H, et al. The costs of atopy and asthma in children: assessment of direct costs and their determinants in a birth cohort. Pediatr Allergy Immunol 2003;14:18–26
   PubMed Web of Science ®Google Scholar
• Iskedjian M, Dupont C, Kanny G, et al. Economic evaluation of a 100% whey-based, partially hydrolyzed formula in the prevention of atopic dermatitis among French children. Curr Med Res Opin 2010;26:2607–26
   PubMed Web of Science ®Google Scholar
• Iskedjian M, Szajewska H, Spieldenner J, et al. Extension of a meta-analysis of the evidence for a partially hydrolyzed 100%-whey formula in the prevention of atopic dermatitis: brief research report. Curr Med Res Opin 2010;26:2599–606
   PubMed Web of Science ®Google Scholar
• Office Fédéral des Statistiques. La population de la Suisse 2009. Neuchâtel: Office Fédéral des Statistiques, Report Number: 349-0900, 2010
   Google Scholar
• Merten S, Dratva J, Ackermann-Liebrich U. Swiss Federal Office of Public Health. Infant feeding during the first 9 months - Swiss National Study 2003. Berne: 2005
   Google Scholar
• Swiss Life Tables 1998/2003. Office fédéral de la statistique. Available at: http://www.bfs.admin.ch/bfsportal/en/index/themen/01/02/blank/dos/la_mortalite_en_suisse/tabl01.html. Accessed March 1, 2011
   Google Scholar
• Compendium Suisse des Médicaments. Document. Documed. Available at: http://www.documed.ch/fr/index.php. Accessed March 1, 2011
   Google Scholar
• Office fédéral de la statistique. Gross activity rate (total population) in 2009. Available at: http://www.bfs.admin.ch/bfs/portal/en/index/themen/03/02/blank/key/erwerbsquote.html Accessed March 1, 2011
   Google Scholar
• International Labour Organization. Hours of work per week by economic activity in Switzerland in 2008 (Table 4A). Available at: http://laborsta.ilo.org. Accessed March 29, 2011
   Google Scholar
• International Labour Organization. Wages by economic activity in Germany in 2008 (Table 5A). Available at: http://laborsta.ilo.org. Accessed March 29, 2011
   Google Scholar
• TPG (Transports Publics Genèvois). Cost of public transportation in Geneva. Available at: http://www.tpg.ch/fr/titres-de-transport/index.php. Accessed March 1, 2011
   Google Scholar
• Genève Tourisme. Cost of taxi in Geneva.Available at: http://www.geneve-tourisme.ch/?rubrique=0000000415. Accessed March 1, 2011
   Google Scholar
• Drummond M, Sculpher M, Torrance G, et al. Methods for the economic evaluation of health care programmes. 3rd edn. Oxford, UK: Oxford University Press, 2006
   Google Scholar
• Swiss Federal Social Insurance Office. Manual for the standardization of clinical and economic evaluation of medical technology (1998 draft). Available at: http://www.ispor.org/PEguidelines/countrydet.asp?c=25&t=1. Accessed May 3, 2011
   Google Scholar
• Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation. Oxford, UK: Oxford University Press, 2008
   Google Scholar
• Pitt M, Garside R, Stein K. A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema. Br J Dermatol 2006;154:1137–46
   Google Scholar
• Coyle D, Barbeau M. Cost effectiveness of elidel in the management of patients with atopic dermatitis in Canada. J Cutan Med Surg 2004;8:405–10
   PubMed Web of Science ®Google Scholar